Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRF vs Vitamin D in Common Warts
NCT07543926Not yet recruiting
- Sponsor
- Sohag University
- Start
- Apr 2026
- Primary completion
- Nov 2026
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Randomised trial of platelet rich fibrin in common warts (2 arms), sponsored by Sohag University. Primary endpoints: Reduction in Lesion Size at 3 months, Patient Satisfaction at 6 months and 2 more. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
platelet rich fibrin
03
Conditions
common warts
Beyond the preview
Go deeper on NCT07543926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07543926.